Delivery Order SPE2DB22D3016-SPE2DB25FAUG0
Award Date 4/21/25
Potential Completion Date 5/12/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,963.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on June 30, 2025, with an ultimate completion date of July 22, 2025. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat various immunodeficiency conditions and autoimmune disorders. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $41,178.10 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an immune globulin intravenous (human) product used in treating immune deficiency disorders and is a critical pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $55,852.80 delivery order on August 18, 2025, for GAMUNEX-C 40 gram/400 ml vials with a completion date of September 9, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapy used to treat immune deficiencies and certain autoimmune and inflammatory...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,468.56 for GAMUNEX-C 1 gram/10 mL vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin used to treat primary immunodeficiency and other...
- The Defense Logistics Agency awarded a $55,852.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on May 9, 2025, with an ultimate completion date of June 2, 2025. GAMUNEX-C is an intravenous immunoglobulin therapy used to treat immunodeficiency conditions and autoimmune disorders. This non-set-aside competitive award represents a single delivery order fulfillment under AmerisourceBergen's broader contract vehicle with the DLA. The work will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $123,534.30 to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on September 28, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin product used to treat various immunodeficiency conditions and immune...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,104.70 for GAMUNEX-C 10 gram/100 mL vials on August 19, 2025, with completion expected by September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapeutic used to treat various immune-related conditions, representing...
- The Defense Logistics Agency awarded a $17,702.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 18, 2025, with an ultimate completion date of October 9, 2025. GAMUNEX-C is an intravenous immunoglobulin used to treat immunodeficiency disorders and autoimmune conditions. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C (10 gram/100 mL vial) valued at $6,104.70 under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 26, 2025. This is a non-set-aside competitive award, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) treatment used to address various...
- The Defense Logistics Agency awarded a $23,272.00 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 Gram/400 ML vials. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 3, 2025. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat various immunological conditions and is a critical pharmaceutical commodity within the federal medical supply chain. The contract is performed at...